NCT01915940 - Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

169

Participants

Timeline

Start Date

October 23, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

November 14, 2014

Conditions

Primary Open-Angle GlaucomaOcular Hypertension

Interventions

DRUG

Bimatoprost

Bimatoprost ocular insert

DRUG

Timolol 0.5%

Timolol 0.5% solution

DRUG

Placebo Eye Drops

Placebo topical eye drops

DEVICE

Placebo Ocular Insert

Ocular insert without any active drug

Trial Locations (10)

27517

UNC Kittner Eye Center, Chapel Hill

30076

Coastal Research Associates, Atlanta

30260

Clayton Eye Center, Morrow

45243

Apex Eye, Madeira

63131

Ophthalmology Consultants, St Louis

76102

Ophthalmology Associates PC, Fort Worth

90701

Sall Medical Research Center, Artesia

92037

Scripps Clinic Torrey Pines, La Jolla

92663

Eye Research Foundation, Newport Beach

95817

UC Davis Dept of Ophthalmology & Vision Science, Sacramento

All Listed Sponsors

lead

ForSight Vision5, Inc.

INDUSTRY